Holdings
Johnson & Johnson
As of Sep 30, 2026, Johnson & Johnson reported 15 positions worth US$762M. Largest: Protagonist Therapeutics, Inc., Nanobiotix SA and MeiraGTx Holdings plc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Protagonist Therapeutics, Inc. | 2.45M | US$345M | no change | Sep 30, 2026 |
| Nanobiotix SA | 5.62M | US$175M | no change | Sep 30, 2026 |
| MeiraGTx Holdings plc | 6.64M | US$73.1M | no change | Sep 30, 2026 |
| Rapport Therapeutics, Inc. | 1.78M | US$60M | no change | Sep 30, 2026 |
| Contineum Therapeutics, Inc. | 1.98M | US$26.6M | no change | Sep 30, 2026 |
| Cerebras Systems Inc. | 129K | US$22.9M | +75,063 | Sep 30, 2026 |
| Xencor, Inc. | 748K | US$18.7M | no change | Sep 30, 2026 |
| Legend Biotech Corp. | 815K | US$16.2M | new | Sep 30, 2026 |
| Fate Therapeutics, Inc. | 3.38M | US$8.01M | no change | Sep 30, 2026 |
| CVRx, Inc. | 4.02M | US$7.04M | no change | Sep 30, 2026 |